Use of a 5-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor for the production of an agent to treat or prevent hyper plastic and/or dysplastic large intestine polyps

摘要

Use of a 5-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase inhibitor (I) for the production of an agent to treat or prevent hyper plastic and/or dysplastic large intestine polyps. ACTIVITY : Gastrointestinal-Gen. MECHANISM OF ACTION : HMG CoA reductase inhibitor; Cyclooxygenase inhibitor.